ARQ 197-209: Overall Survival (ITT Population) HR = 0.88 (95% CI: 0.60, 1.3); p = 0.50 Adjusted HR = 0.88 (95% CI: 0.6, 1.3); p = 0.52* Erlotinib + ARQ 197: 36.6 wks (n = 84) Erlotinib + placebo: 29.4 wks (n = 83) 010203050704060 Survival time (weeks) 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of patients surviving 0.1 0.3 0.5 0.7 0.9 *Cox regression model With permission from Schiller JH et al.
{}